Solid‐phase extraction treatment is required for measurement of active glucagon‐like peptide‐1 by enzyme‐linked immunosorbent assay kit affected by heterophilic antibodies

AIMS/INTRODUCTION: It is reported that interfering substances in the blood might influence the value for measurement of active glucagon‐like peptide‐1 (GLP‐1) in human plasma. Solid phase extraction (SPE) pretreatment is recommended to reduce their influence, but it requires a lot of cost and time....

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Tomonori, Komagata, Miho, Hamasaki, Akihiro, Harada, Norio, Seino, Yutaka, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400240/
https://www.ncbi.nlm.nih.gov/pubmed/29993194
http://dx.doi.org/10.1111/jdi.12896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400240/
https://www.ncbi.nlm.nih.gov/pubmed/29993194
http://dx.doi.org/10.1111/jdi.12896

Ejemplares similares